Cargando…
mRNA-Based Approaches to Treating Liver Diseases
Diseases that affect the liver account for approximately 2 million deaths worldwide each year. The increasing prevalence of these diseases and the limited efficacy of current treatments are expected to stimulate substantial growth in the global market for therapeutics that target the liver. Currentl...
Autores principales: | Cacicedo, Maximiliano L., Limeres, María José, Gehring, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601253/ https://www.ncbi.nlm.nih.gov/pubmed/36291194 http://dx.doi.org/10.3390/cells11203328 |
Ejemplares similares
-
Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022) -
Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
por: Kaps, Leonard, et al.
Publicado: (2023) -
mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022) -
Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy
por: Cacicedo, Maximiliano L., et al.
Publicado: (2020) -
mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)